Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 14/20 | 0.57 |
| ▸ | LIPE | Q05469 | 1/20 | 0.45 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.44 |
| ▸ | CTSA | P10619 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1950749 | 0.89 | PTGDR2 (0.62) | PTGDR2LIPEABHD6PPARD | |
| SCHEMBL3671898 | 0.87 | LIPE (0.46) | PTGDR2LIPEABHD6CTSAMGLL | |
| SCHEMBL3671902 | 0.87 | LIPE (0.46) | PTGDR2LIPEABHD6MGLL | |
| SCHEMBL12542896 | 0.85 | PTGDR2 (0.52) | PTGDR2LIPEABHD6PPARDMGLL | |
| SCHEMBL1949600 | 0.84 | PTGDR2 (0.56) | PTGDR2CTSAPPARD | |
| SCHEMBL1947876 | 0.83 | PTGDR2 (0.64) | PTGDR2PPARD | |
| SCHEMBL1948807 | 0.81 | PTGDR2 (0.59) | PTGDR2PPARD | |
| SCHEMBL1948090 | 0.81 | PTGDR2 (0.61) | PTGDR2PPARD | |
| SCHEMBL1950917 | 0.80 | PTGDR2 (0.54) | PTGDR2CTSAPPARD | |
| SCHEMBL1948555 | 0.79 | PTGDR2 (0.64) | PTGDR2PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110136877-A1 | 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS | LIGAND PHARMACEUTICALS INC. (US) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136877-A1 | 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS | HCAR2, PAH, PTGES2 | PTGDR2 15/4885LIPE 1540/4885ABHD6 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.